In a widely watched Senate confirmation hearing, Dr. Mehmet Oz, nominated by Trump to head the Centers for Medicare and Medicaid Services (CMS), faced rigorous questioning from senators regarding his stance on critical health care issues. While he pledged to continue Medicare drug price negotiations initiated by the Biden administration and vowed to combat healthcare fraud, he declined to commit to opposing potential Medicaid cuts. Oz was also grilled about past tax allegations concerning his Medicare and Social Security contributions, with Democrats suggesting he may have skirted these obligations. Despite his attempts to charm the committee, he faced skepticism about his ties to the insurance industry and the implications for crucial health programs. As he seeks to navigate these challenges, Dr. Oz emphasized the need for faster Medicare coverage decisions and highlighted concerns over a looming health crisis and Medicare bankruptcy.